Editas Medicine, Inc 10-Q for FY2021 Q3
Editas Medicine, Inc. (EDIT)
10-Q
2021-11-09
For: 2021-09-30
View Original
Added on
April 10, 2026
About this 10-Q
Editas Medicine, Inc filed this 10-Q on November 9, 2021, covering the quarter ended September 30, 2021 (FY2021 Q3).
Headline figures
Quarter ended September 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $6.2M
- down 90.1% from $62.84M a year earlier
- Net loss
- $39.08M
- compared with net income of $7.82M a year earlier
- Diluted EPS
- -$0.57
- compared with $0.12 a year earlier